JCHOR
Journal of Current Hematology & Oncology Research

The Journal of Current Hematology & Oncology Research regularly publishes internationally qualified research in hematology and oncology within the current scholarly knowledge. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

ISSN: Active
eISSN: 2980-0854
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Original Article
Effect of vitamin D on prognosis in patients with gastric cancer
Abstract
Aims: In the Eastern Anatolia Region of Turkey it is estimated that the gastric cancer is seen more frequently compared to other regions. As is well known, a reduction in the incidence of certain cancers with high vitamin D value was identified, and vitamin D has been shown to have positive effects on the prognosis of these diseases. In our study, we aimed to investigate the relationship between vitamin D values before treatment and prognosis in patients with gastric cancer.
Methods: This study includes 76 patients who had diagnosis of gastric cancer for the first time and admitted to Oncology Clinic in Van Yuzuncu Yil University Faculty of Medicine (YYU) Hospital. Patients inclusion criterias have been identified as lack of story for recently blood transfusion, treatment with any medication and being taken any mineral supplements. Patients vitamin D and tumor markers values were measured at diagnosis. Vitamin D values at diagnosis and stage of the disease, 6. 12. month mortality and disease progression were compared.
Results: A total of 76 patients were included in the study. Mean value of vitamin D was 16.1 (3-27). There was not a significant correlation between vitamin D value and stage of disease. Mean age was 60(33-89). Of the patients 26 (34.2 percent) had no metastasis, 15 (19.2 percent) had only liver metastasis, 8(10.5 percent) had only lung metastasis and 27(35.5 percent) had two or more region metastasis.
Conclusion: In our study, vitamin D deficiency was present in all gastric cancer patients regardless of stage, indicating that vitamin D deficiency is a poor risk factor in gastric cancer.

Keywords : Gastric cancer, vitamin D value, prognosis

Download Article


1. Shah MA, Kelsen DP. Gastric cancer: a primer on the epidemiologyand biolgy of the disease and onerview of the medical management ofadvanced disease. J Atl Compr Canc Netw. 2010;8(4):437-447.
2. Holick MF. Vitamin D: its role in cancer prevention and treatment.Prog Biophys Mol Biol. 2006;92(1):49-59.
3. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CACancer J Clin. 2002;52(1):23-47.
4. Boccia S, La Torre G, Gianfagna F, Mannocci A, Ricciardi G.Glutathione S-transferase T1 status and gastric cancer risk: a meta-analysis of the literature. Mutagenesis. 2006;21(2):115-123.
5. Stewart BW, Kleihues P, eds. World Cancer Report. IARCPress: 2003.
6. Apperly FL. The relation of solar radiation to canser mortality in NorthAmerican. Canser Res. 1941;1(3):191-195.
7. Gerland FC, Gerland FC. Do sunlight and vitamin D reduce thelikehood of colon canser? Int J Epidemiol. 1980;9(3);227-231.
8. Giovannuci E. Commentary: vitamin D and colorectal cancer-twenty-five years later. Int J Epidemiol. 2006;35(2):222-224.
9. Wacker M, Holick MF. Vitamin D-effects on skeletal and extraskeletalhealth and the need for supplementation. Nutrients. 2013;5(1):111-148.
10. Parkin DM. International variation. Oncogene. 2004;23(38):6329-6340.
11. Memik F, Gulten M, Nak SG, et al. The epidemiology of gastrointestinalcancer in Turkiye: a review of our accumulated experience. J EnvironPathol Toxicol Oncol. 1996;15(2-4):209-213.
12. Tuncer İ, Uygan İ, Kösem M, Özen S, Uğraş S, Türkdoğan K. Thedemography and histopathologic characteristics of upper gastrointestinalcancers appeared in Van and its vicinity. Van Med J. 2001;8(1):10-13.
13. Muller DC, Fanidi A, Midttun I, et al. Circulating 25-ydroxyvitaminD3 in relation to renal cell carcinoma incidence and survival in theEPIC cohort. Am J Epidemiol. 2014;180(8):810-820.
14. Barreto SG, Neale RE. Vitamin D and pancreatic cancer. Cancer Lett.2015;368(1):1-6.
15. Abulkhair O, Saadeddin A, Makram O, et al. Vitamin D levels andbreast cancer characteristics: findings in patients from Saudi Arabia. JSteroid Biochem Mol Biol. 2016;100(164):106-109.
16. Giovannucci E, Liu Y, Willett WC. Cancer incidence and mortalityand vitamin D in black and white male health professionals. CancerEpidemiol Biomark Prevent. 2006;15(12):2467-2472.
17. Colston K, Colston MJ, Feldman D. 1,25-OH(2)D3 and malignantmelanoma: the presence of receptors and inhibition of cell culture.Endocrinol. 1981;108(3):1083-1086.
18. Abe E, Miyaura C, Skagami H, et al. Differentiation of mouse myeloidleukemia cells induced by 1,25- OH(2)D3. Proc Natl Acad Sci. 1981;78(8):4990-4994.
19. Özkan B, Döneray H. D vitamininin iskelet sistemi dışı etkileri. ÇocukSağ Hast Derg. 2011;54(2):99-119.
20. Mc Guire TF, Trump DL, Johnson CS. Vitamin D (3)-induced apoptosisof murine squamous cell carcinoma cells. Selective induction ofcaspasedependent MEK cleavage and up-regulation of MEKK-1. J BiolChem. 2001;276(28):26365-26373.
21. Wong G, Lim WH, Lewis J, et al. Vitamin D and cancer mortality inelderly women. BMC Cancer. 2015;15(1):106.
22. Trivedi DP, Doll R, Khaw KT. Effect of four-monthlyoral vitaminD3 (cholecalciferol) supplementation onfractures and mortality inmen and women living inthe community: randomised double blindcontrolledtrial. BMJ. 2003;326(7387):469.
23. Khayatzadeh S, Feizi A, Saneei P, Esmaillzadeh A. Vitamin D intake,serum Vitamin D levels, and risk of gastric cancer: a systematic reviewand meta-analysis. J Res Med Sci. 2015;20(8):790-796.
24. Ren C, Qiu MZ, Wang DS, et al. Prognostic effects of 25-hydroxyvitaminD levels in gastric cancer. J Transl Med. 2012;10(1):16.
25. Baek S, Lee YS, Shim HE, et al. Vitamin D3 regulates cell viability ingastric cancer and cholangiocarcinoma. Anat Cell Biol. 2011;44(3):204-209 doi: 10.5115/acb.2011.44.3.204
26. Abnet CC, Chen Y, Chow WH, et al. Circulating 25-hydroxyvitamin Dand risk of esophageal and gastric cancer: cohort consortium vitaminD pooling project of rarer cancers. Am J Epidemiol. 2010;172(1):94-106.
Article available in :
Volume 2, Issue 1, 2024
Page : 1-5
https://doi.org/10.51271/JCHOR-0026
Article Information
Received : 08 Ara 2023
Accepted : 05 Oca 2024
Published : 12 Şub 2024
Corresponding Author :

Yasin Sezgin: Van Yüzüncü Yıl University

[email protected]
Citation : Sezgin Y, Aydın İ, Biçer A, Can A. Effect of vitamin D on prognosis in patients with gastric cancer. J Curr Hematol Oncol Res. 2024;2(1):1-5.

Read: 573
Cited: 0
Download : 174
_Footer